Drug recall · April 7, 2021
Acyclovir Sodium Injection 1000mg/20mL recall
Why: Crystallization: customer complaints for crystallization in finished product.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India. Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.
- Lots / codes
Lot#: L000155, Exp 12/2021; L000156, Exp 1/2022
- Quantity
- 816 packs
- Company
- Zydus Pharmaceuticals (USA) Inc, Pennington, NJ
- Distribution
- USA Nationwide
- Initiated
- February 18, 2021 · Voluntary: Firm initiated
- Classified
- March 30, 2021
- Reported
- April 7, 2021
- Ended
- November 23, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Acyclovir
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.